T he presence of a proinfl ammatory milieu in the airway is important for the development of a range of infl ammatory lung diseases. Adequate assessment of infl ammatory cells, cytokines, chemokines, and antiinfl ammatory molecules is essential for understanding, monitoring, and treating these disorders. Induced sputum provides a noninvasive means of investigating airways infl ammation. 1 Induced sputum has a fl uid phase containing a heterogeneous mix of proteins and nonorganic substances. A number of cytokines, including interleukin (IL)-8, have been measured, 2 albeit with signifi cant interstudy variation in reported levels. 3 The nonorganic component, however, has been largely neglected.
Sputum Induction
Sputum induction was performed by a standard method as previously described. [15] [16] [17] In brief, patients inhaled nebulized hypertonic saline at concentrations of 3%, 4%, and 5% and were asked to expectorate after each inhalation until a sample was obtained. Patients with CF underwent induction unless freely expectorating in keeping with previous CF sputum studies. 18, 19 Nine of 23 subjects with CF spontaneously produced sputum without induction.
Sputum Processing
Sputum was processed within 2 hours of collection as described previously. 15 In brief, sputum plugs were harvested and processed with 4 3 weight/volume of 0.1% dithiothreitol in phosphate-buffered saline (PBS), after which 4 3 weight/volume of PBS was added. Samples were fi ltered through 48-m m mesh and centrifuged at 1,200 rpm to remove the cells. Supernatant was stored at 2 80°C until further analysis without protease inhibitor. The cell pellet was resuspended in PBS and used for cytospin preparation. Cytospins were stained with May-Grunwald-Giemsa for differential cell counting. All cell counts were expressed as percentage of the population counted. Total cell count was not performed prior to cytospin. All samples used in this study contained , 40% squamous cells.
Trace Element Assay
Trace element assay was performed in the Scottish National Trace Element Reference Laboratory, Glasgow, Scotland. A four-point calibration was used (0, 100, 500, 1,000 m g/L copper, iron, zinc, manganese in 1% nitric acid). Sputum samples were centrifuged at 800 g for 5 min and 200 m L of sample was then diluted with 2 mL internal standard solution (100 m /L yttrium in 1% nitric acid) and mixed by inversion. Internal accuracy was assessed by use of two aqueous certifi ed reference materials, TMDA62 and TMDA64 (Prochem; Chessington, England). Trace element levels were measured by inductively coupled plasma optical emission spectrometry using a VISTA AX (Varian; Oxford, England).
Measurement of Sputum IL-8, Myeloperoxidase, and Calprotectin
To compare the results of metals in sputum with biochemical markers of infl ammation, comparisons with IL-8, myeloperoxidase (MPO), and calprotectin were made in the CF group. Immunoassays used commercially available sandwich enzyme-linked immunosorbent assay kits, following the manufacturer's instructions. The kits used were IL-8 (Biosource Europe SA; Nivelles, Belgium ), MPO (Assay Designs Inc; Ann Arbor, MI), and Calprotectin (Buhlmann Laboratories, AG; Schonenbuch, Switzerland ).
Data Analysis
Data analysis was carried out on GraphPad Prism software (GraphPad; La Jolla, CA ) for Windows. Cross-sectional data were nonnormally distributed and were analyzed by Kruskal-Wallis analysis of variance and Dunn multiple comparison test. P , .05 was considered signifi cant. For longitudinal analysis of zinc and iron data a paired Student t test was performed. For correlation, data were subjected to Spearman rank analysis.
Results

Subject Demographics
The demographic profi les and sputum cytology of each group are shown in Table 1 . The CF group was aureus growth through the chelation of zinc and manganese. 8 Increased levels of total iron and iron-binding proteins have been reported in the sputum of patients with cystic fi brosis (CF) and COPD. [9] [10] [11] [12] Scavenging of free iron is an important component of antimicrobial defense mechanisms against organisms such as Pseudomonas aeruginosa , 13 an important pathogen in chronic lung disease. Although iron is clearly an important inorganic substance in the airway, other metals, such as zinc, may also be important; for example, increased zinc levels alter the sensitivity of Pseudomonas , an organism particularly relevant to CF lung disease, to antibiotics. 14 Therefore the measurement of trace elements in sputum may allow mechanistic insight into diseases such as CF. Furthermore, trace elements, likely to be less susceptible to protease activity, may allow more reliable measurement of infl ammation in the airway. Thus we feel that measurement of trace elements may allow a more robust sputum measurement of airways disease as well as giving further insight into lung infl ammation in diseases such as CF.
Based on our previous fi ndings of increased levels of calprotectin, a known chelator of zinc, in the airway and previous observations related to iron in the CF airway we hypothesized that trace metal concentrations, in particular zinc and iron, would be elevated in CF and non-CF bronchiectasis compared with control populations. We also hypothesized that levels of trace element would change following disease intervention in CF. Total concentrations of zinc, iron, copper, and manganese were measured in subjects with CF, bronchiectasis, COPD, and asthma, and in normal controls. Furthermore, concentrations of trace elements were compared with previously described markers of infl ammation in CF, including calprotectin.
Materials and Methods
Subjects
Induced sputum was obtained from patients attending the Respiratory Unit at the Western General Hospital, Edinburgh. Approval was obtained from the local regional ethics committee. Twenty-three patients with CF, 16 with non-CF bronchiectasis, 17 with asthma, 23 with COPD, and 20 healthy controls were studied. In order to monitor the effects of a changing state of infl ammation, sputum samples were obtained from 14 additional patients with CF during CF exacerbation. Exacerbation samples were taken within 24 hours of starting antibiotic therapy and at the end of treatment.
Reagents Used
All reagents were purchased from Sigma (Sigma; Gillingham, UK ) unless otherwise stated. Ultrapure, high-performance liquid chromatography-grade water was used for all experiments and preparations. Aristar nitric acid was used in the trace element assay. signifi cant effect on the zinc or iron levels in the COPD group ( Fig 1 ) .
Sputum manganese differentiated non-CF bronchiectasis but not CF from control ( P , .05). Sputum manganese also differentiated subjects with asthma from control subjects ( P , .01). Sputum copper was higher in all disease groups vs control but only reached statistical signifi cance for CF ( P , .01).
In some subjects trace element levels were below the limit of detection of the assay, in particular for manganese. Interestingly, zinc and iron were detectable in all subjects with CF. Please refer to Table 2 for further information.
Correlation of Sputum Zinc and Iron Levels With Lung Function, Sputum Cytology, and Sputum Biomarkers in Patients With CF
As the most statistically signifi cant changes were seen in the CF group, further comparisons were made with clinical data and other infl ammatory markers for this group. Sputum zinc and iron levels were correlated in patients with CF (Spearman r 5 0.75, P , .05, data not shown). There was a negative correlation of zinc and FEV 1 % predicted in the CF group (Spearman r 5 2 0.469, P , .05, Fig 2 A ). Sputum iron was also negatively correlated with FEV 1 % (Spearman r 5 2 0.43, P , .05, data not shown). Sputum neutrophil % and zinc levels were correlated (Spearman r 5 0.67, P , .05, data not shown). Zinc younger than the control and other disease groups ( P , .01). Of the COPD group 10 were current smokers, nine ex-smokers, and four gave no information on current smoking status. Of the patients with CF, 14 were colonized with P aeruginosa , the other patients being colonized by a variety of organisms, including Stenotrophomonas maltophilia and Burkholderia cenocepacia species.
Assay Reproducibility
Pooled samples of fi ve subjects in each group of control, CF, and non-CF bronchiectasis were assayed in two separate runs for zinc levels with co effi cients of variance of 14.7%, 2.7%, and 5.4%, respectively, giving an average coeffi cient of variation of 7.6%.
Sputum Trace Element Levels in Cross-Sectional Data
The absolute concentrations of zinc, iron, and manganese are displayed in Table 2 in m g/L. Sputum zinc concentration was at least fourfold higher in CF and non-CF bronchiectasis than controls ( P , .001). Concentrations in CF and non-CF bronchiectasis were also higher than in asthma and COPD ( P , .05).
Sputum iron was at least twofold higher in CF and non-CF bronchiectasis than controls ( P , .01) and COPD ( P , .05). Levels were higher in the COPD and asthma groups vs controls but did not reach statistical signifi cance. Current smoking status had no Data are displayed as: median (interquartile range). P values are displayed for disease group vs control; for P values between groups please consult text. Zinc was below the limit of detection of the assay in four control and one COPD. Iron was below the limit of detection in four control, one asthma, and one COPD. Manganese was below the limit of detection in 14 control, three asthma, 13 COPD, six CF, and one bronchiectasis. See Table 1 for expansion of abbreviation. a P , .01 vs control. b P , .001 vs control. c P , .05 vs control.
subjects. There is a small degree of overlap between the CF and control groups, but this may be explained by the fi nding that patients with CF in this small subgroup had better lung function and thus less severe lung disease (data not shown). Sputum zinc levels were also signifi cantly higher in CF and non-CF bronchiectasis compared with COPD. Sputum zinc levels decrease signifi cantly over the course of a CF exacerbation. Zinc is strongly correlated with calprotectin in CF sputum as well as with other infl ammatory markers, such as IL-8 and MPO. Protein biomarkers, such as cytokines, have been used in previous studies to assess levels of airways infl ammation. [20] [21] [22] However, protease activity in expectorated sputum may affect the robustness of cytokine assays. 23 The potential association we have shown between trace element levels and infl ammation in sputum samples combined with their likely resistance to degradation commends them as potentially robust markers of lung pathophysiology.
Serum zinc has previously been suggested as a marker of lung disease, 24, 25 but we believe this to be the fi rst study to describe an association between sputum zinc and infl ammation in individuals with CF lung disease and non-CF bronchiectasis. Furthermore, we demonstrate its potential use as a serial marker during treatment of an exacerbation, although this must be interpreted with caution as in two subjects zinc levels actually increased, whereas in four others there was only a modest decrease of levels. Nevertheless, the majority of subjects demonstrated a decrease with treatment and as such further investigation is clearly merited.
We thus suggest that sputum zinc may be used as a biomarker in suppurative diseases, such as CF. We do realize, however, that as we have used a relatively small sample size, albeit similar to those use in previous biomarker studies, these data represent a novel observation and further validation in larger studies is required. Furthermore, a parallel measure of zinc in serum may have added further insight into the functional signifi cance of these fi ndings, as would knowledge of individual subject dietary zinc intake.
Zinc homeostasis may play an important role in modulating the immune response to infl ammation, with high concentrations of zinc inducing peripheral blood monocyte apoptosis 26 and promoting cytokine production. 27 Conversely, low concentrations of zinc may suppress monocyte function and decrease neutrophil phagocytosis. 28 Zinc may also interact with the airway epithelium. 29, 30 For example, zinc deprivation of bronchial epithelial cells in culture induces apoptosis, 31, 32 and zinc defi ciency in a murine model of asthma induces epithelial cell apoptosis and airways infl ammation. 33 We have measured total zinc content of sputum (ie, bound and unbound), whereas levels were unrelated to the underlying colonizing organism (data not shown).
Sputum zinc and calprotectin levels correlated with high statistical signifi cance (Spearman r 5 0.86, P , .001 , Fig 2 B ). Sputum zinc signifi cantly correlated with MPO and IL-8 (Spearman r 5 0.81, P , .001, Spearman r 5 0.67, P , .001, respectively, Figures 2 C and 2 D ). Sputum iron demonstrated similar but less signifi cant correlations to calprotectin, MPO, and IL-8 (data not shown).
Serial Measurement of Metals in CF Exacerbation
Sputum zinc levels decreased signifi cantly following antibiotic therapy for an exacerbation ( P , .01; Fig 3 ) . There were no signifi cant serial changes in iron, manganese or copper.
Discussion
Total elemental zinc and iron concentrations are elevated in sputum from subjects with CF and non-CF bronchiectasis compared with healthy control prerequisite for microbial growth, with increased levels in CF sputum possibly contributing to the proliferation of bacteria such as P aeruginosa . 11 The source of this iron is unclear, with leak from the circulation being suggested, although further work is required to investigate this. Cigarette smoke has also been suggested as a potential source of airways iron, 35 but we have demonstrated no difference in sputum iron between current smokers and ex-smokers with COPD in this study.
Associations between the levels of sputum manganese and copper with disease type are less obvious. Manganese was only signifi cantly elevated in the asthma and non-CF bronchiectasis groups and copper only in CF. Both metals (like zinc) are cofactors for superoxide dismutases (SODs) , which have leading roles in alleviating oxidative stress in the lung. 36 Furthermore, the demonstration that manganese differentiated subjects with asthma from control subjects but not subjects with CF from control subjects suggests a possible role for this element in nonsuppurative lung disease. SODs are downregulated in asthmatic airways, 36 suggesting sputum copper and manganese are not merely tracking levels of these mediators. A measurement of SOD level or activity would help to elucidate this complicated relationship but was not performed in this study and thus forms the basis of future work by this group.
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Elevated levels of calprotectin and zinc may refl ect passive release of the neutrophil contents in view of the large number of necrotic neutrophils in the CF airway, 41 or may represent active secretion as is observed with lactoferrin release from neutrophils. 42 A passive release of zinc, on cell necrosis, would be supported by the correlation of zinc with both neutrophil percentage in samples and calprotectin, a cytoplasmic protein in neutrophils. A more controlled active release of zinc may be suggested, however, by the correlation of zinc with MPO, a neutrophil granule protein released from activated neutrophils. Nevertheless, the higher correlation is of zinc, and calprotectin might simply refl ect an overall abundance of neutrophils, which are rich in both of these substances, 43, 44 as neutrophils contain 5 to 10 ng zinc per 10 6 cells. 43 It is also important to consider that the zinc we have measured in the airway could also be complexed to calprotectin (or other proteins) or could be due to leakage from the pulmonary circulation during infl ammation.
In conclusion, we have demonstrated elevated levels of trace metals (zinc in particular) in the fl uid phase of sputum from patients with CF and non-CF bronchiectasis compared with patients with asthma or COPD and healthy adult controls. We also demonstrate that the level of zinc in CF sputum decreases over the course of an infective exacerbation and the use of chemically stable markers in noninvasive assays to monitor the course and severity of lung diseases such as CF would clearly be advantageous. Of course a valid biomarker must be highly reproducible and repeatable and, as such, longitudinal studies to evaluate the robustness of sputum trace metal assays of infl ammation are required.
